Systemic Lupus Erythematosus (SLE) is an autoimmune disorder affecting almost all organs and tissues. Dermatomyositis (DM) is a chronic muscle disorder that leads to muscle destruction. Although DM mechanisms remain unclear, there is an evidence of autoimmune origin. Toll-like receptors (TLRs) are the key initiators of innate and adaptive immune response due to high production of proinflammatory mediators and activation of antigen presentation. We used qPCR to investigate the expression of TLR4 and TLR9 in peripheral blood mononuclear cells (PBMCs) from SLE and DM patients, as well as muscle tissue biopsies from the DM patients, to explore their role and study their correlations with clinical manifestations and disease activity. Our findings showed a significant increase in TLR4 and TLR9 expression levels in PBMCs from SLE patients and muscle biopsies from DM patients. Such results emphasize the role of TLR signaling and innate immune system in the pathogenesis of both diseases.
INTRODUCTION
SLE is an autoimmune disorder of multifactorial origin, in genetically predisposed subjects, environmental factors, such as viral infections and smoking, induce the breakdown of self-tolerance eventually triggering autoimmune response (Tsokos, 2011). It is characterized by spontaneous lympho-proliferation, aberrant activation of T and B cells and production of auto-antibodies against nuclear DNA and / or other nuclear proteins (Mu et al., 2012). DM is a chronic muscle disorder, clinically characterized by features of symmetric proximal muscle weakness. DM is a microangiopathy affecting the skin and muscle, in which the early activation and deposition of complement causes the lysis of endomysial capillaries and muscle ischemia. Perimysial and perivascular inflammation with CD4+T cell, B cells, and macrophage infiltrations are the histological features of DM (Kim et al., 2010). TLRs is one of a group known as pattern recognition receptors that play a critical role in protective immunity against invading microorganisms. Pathogens, especially bacteria, have molecular structures that are not shared with their host and are relatively invariant named as Pathogen Associated Molecular Pattern (PAMPs) that are recognized by those TLRs such as bacterial DNA, flagellin, viral double stranded RNA (Pradhan et al., 2012).
At least 12 mammalian TLR family members have been identified, TLR1, -2, -4, -5 and -6 are on the cell surface and they interact with components found on the surface of pathogens whereas TLR3 and -7, -8 and -9 -are expressed within intracellular vesicles and their ligands must be taken up into the endosome to result in activation (Blasius and Beutler, 2010). Intracellular TLRs, apart from being able to recognize PAMPs they are also capable of recognizing endogenous ligands which are named Danger Associated Molecular Patterns (DAMPs) (Denk et al., 2012). In SLE patients, impaired apoptosis and invalid cell debris clearance lead to increased concentration of serum nucleic acids (ssRNA, dsRNA, and DNA), which are well-known ligands for TLR so Immune response is induced by not only microbial infection, but also by sterile tissue damage and degeneration product (Ma et al., 2015) . TLR activation leads to expression of genes such as inflammatory cytokines and co-stimulatory molecules. Eventually, antigen-specific patients (82%) had Constitutional symptoms in the form of fever, malaise, weight loss , 12 patients (71%) had calcinosis, 10 (59%) had arthritis, 4 patients (23.5% ) had muscle power grade 3 and 14 (82%) had muscle power grade 4 of the shoulder and /or pelvic girdle muscles. The control group included twenty subjects (14 females, 70%) and 6 males, 30 %) (F/M = 7/3). Their ages ranged between 10-54 years with a mean of (31.3±13.3) years. The data retrieved from our study revealed that the expression levels of TLR4 and TLR9 were significantly higher in the PBMCs from SLE patients compared to that of the controls (P<0.05). Table ( 3) In addition, TLR4 expression levels in the PBMCs of SLE were significantly higher in those patients who had malar rash (P<0.05), alopecia (P<0.05), arthritis (P<0.05) and pericarditis (P<0.05). On the other hand, TLR4 mRNA expression showed a significant negative correlation with corticosteroid doses (r=-0.54, P<0.05). Regarding TLR9 expression levels, they were higher in SLE patients with nephritis (P<0.05) and positively correlated with the protein /creatinine ratios (r=0.47, P<0.05), the SLICC damage indices (r=0.59, P<0.05) and negatively correlated with C3 levels (r=-0.53, P<0.05). In DM, TLR4 and TLR9 expression levels in the PBMCs showed insignificant difference between the patients and the control subjects (P>0.05) for both genes. However, their expression levels in the muscle biopsies from DM patient group were significantly higher (P<0.05) than in the muscle tissue from the control Table (4) . Comparing the muscle biopsies to the PBMCs in DM patients showed significant higher TLR4 and TLR9 expression levels (both P<0.05). In the muscle biopsies from DM patients, both TLR4 and TLR9 expression levels, positively correlated with disease activity scores (DAS) (P<0.05) as well as with creatine kinase (IU/L) levels (P<0.05, respectively). Furthermore, our results indicated that TLR9 expression levels were significantly higher in patients who had calcinosis (P<0.05). However, only TLR4 expression levels exhibited a significant negative correlation with corticosteroid doses (P<0.05). C3= complement 3, C4 = complement 4, ANA= anti-nuclear antibodies, Anti ds -DNA= anti double stranded deoxy nucleic acid. RU: Relative Units, * P < 0.05 significant RU: Relative Units, * P ≤ 0.05 significant DISCUSSION Autoreactive B cells, present in the lymphoid tissue of healthy individuals remain silent due to presence of self-tolerance mechanisms. Upon failure of self-antigen tolerance, the antigen receptors co-engage with self-reactive antibodies, leading to activation of these autoreactive B cells and development of autoimmune diseases. TLRs that have been triggered by self-antigens, are suggested to respond to signals received by innate immune system, by induction of the secretion of inflammatory cytokines, thereby engaging lymphocytes to support an adaptive, antigen-specific immune response (Pradhan etal., 2012) (Lim & Staudt, 2013) .
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Our findings revealed significantly higher mRNA expression regarding TLR4 and TLR9 in PBMCs from SLE patients as compared to that of control subjects. As far as we know, this is the first study to assess TLR4 expression in PBMCs from SLE patients using qRT-PCR. The present results denote that it was upregulated in the patient group as compared to the control group. In spite of the lack of previous studies using the same technique, this finding supports the previous results showing that the protein expression of many TLRs including TLR4 and 9 in PBMCs of SLE patients compared to control subjects ( In our SLE patients, TLR4 expression was significantly higher in those with malar rash, alopecia, arthritis and cardiac manifestations (all P<0.05). While, TLR9 expression was significantly higher in patients with nephritis, positively correlated with protein/creatinine ratios, and mean SLICC damage indices (P<0.05). Previous experimental studies highlighted the role of TLR4 in the pathogenesis of SLE. It has been shown that overexpressing TLR4 alone mice is sufficient to induce lupus-like autoimmune disease. (Liu  et al., 2006 ) Moreover, TLR4 deficient mice showed significant decrease of autoantibodies rates. Interestingly, TLR4 has been reported to synergize with TLR7&9 ligands. Upon activation, TLR4, 9 transmit the signals through different adaptor molecules to activate dendritic cells (DCs), increase circulating cytokines levels specially IFN-I and finally enhance the disease (Crampton et al., 2014) . The present results regarding higher mRNA expression of TLR4 in SLE patients with malar rash, alopecia, arthritis and cardiac manifestations, could be attributed to the increased level of interferon type I (IFN-I) et al., 2010) ; an imbalance that is thought to be of pathogenic significance in rheumatoid arthritis (Dolhain et al., 1996) . Moreover, TLR4 deficiency in mice models confers protection against the inflammatory process of rheumatoid arthritis due to the lowered capacity to produce interleukin-17 (Wong et al., 2010) . Interestingly, animal studies of SLE have implicated TLR9 as a receptor for hypomethylated DNA. SLE patients have higher level of nuclear debris with hypomethylated CpG-DNA that may serve as autoantigens to trigger TLR9 expression and exacerbate the inflammatory process through increased inflammatory cytokines levels including IFN-I (Yasuda et al., 2009) (Christensen et al., 2006) . Our results showed that TLR9 relative expression was significantly higher in SLE patients with positive anti-dsDNA antibodies (P<0.05). This is consistent with reports detecting a positive correlation between increased expression of TLR9 mRNA and the presence of anti-ds DNA antibody (Mu et al., 2012) . One possible mechanism is that autoantigens can bind B cell receptors and trigger TLR9 expression, which results in B cell activation, proliferation, production and class-switching of autoantibody (Leadbetter et al., 2002) ( Lin et al., 2004) . This suggestion was ascertained by another study which showed that the production of anti-dsDNA antibodies was inhibited in TLR9-deficient lupus-prone mice (Christensen et al., 2006) . On the contrary, a negative correlation was observed between antidsDNA autoantibodies and the TLR9 mRNA content in cells (Komatsuda et al., 2008) . Nevertheless, the difference may be explained by the heterogeneity of studied populations (Lartigue et al.,  2009 ). On the other hand, TLR4 mRNA expression in SLE patients inversely correlated with corticosteroid doses. The occurrence of profound suppression of TLR 1, -2, -3, -4, -6 and 9 in liver sinusoidal (Kim et al., 2010) . In our study, TLR4 and TLR9 were upregulated in the muscle tissue of DM group versus that of the control group. Though, their expression showed insignificant difference in PBMCs from subjects of both groups. These results are in agreement with the results of a former study reporting that the mRNA expression levels of TLR4 were significantly higher in the muscle tissue of the patients group compared to those of the controls (Brunn et al., 2012). The possible mechanisms of TLR overexpression stems from the contribution of either various microbial pathogens considered as etiologic agents, or the endogenous molecules and cytokines that are generated during muscle damage or immune response. Our study showed that within DM group, TLR4 and TLR9 expressions in muscle tissue were statistically significantly higher (P<0.05) than that in the PBMCs of the same group and are statistically significantly correlated with the DM Disease Activity Score (DAS) and CK levels. However, only TLR4 expression negatively correlated with corticosteroid doses. Excessive physical activity and strenuous exercise in normal individuals leads to modest elevations in serum muscle enzymes such as creatine kinase (CK), whereas myositis patients generally show a significant increase in CK, suggesting that skeletal muscle leakiness and damage occur in this disease. It is likely that some DAMPs leak from the injured skeletal muscle and engage their receptors on both skeletal muscle and immune cells, thereby perpetuating the inflammatory process (Brunn et al., 2012) .
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CONCLUSION
Our results may suggest a detrimental role of TLR4, TLR9 signaling and innate immune system in the pathogenesis of SLE and DM through activation of TLR pathway. Moreover, the results propose that targeting TLRs and their signaling pathways may lead to development of a new class of efficacious drugs for down-streaming the auto-inflammatory response and control disease activity in both SLE and DM disorders.
